Skip to main content
رجوع
SYK logo

Stryker Corporation

جودة البيانات: 100%
ذروة بيع
SYK
NYSE Healthcare Medical - Devices
KWD 328.51
▼ KWD 4.08 (-1.23%)
القيمة السوقية: 125.72B
نطاق اليوم
KWD 327.21 KWD 331.62
نطاق 52 أسبوعًا
KWD 327.21 KWD 404.87
حجم التداول
1,664,741
متوسط 50 يوم / 200 يوم
KWD 363.32 / KWD 372.67
الإغلاق السابق
KWD 332.59

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (627 نظير)

المقياس السهم وسيط القطاع
P/E 38.7 0.4
P/B 5.6 2.9
ROE % 15.1 3.9
Net Margin % 12.9 3.8
Rev Growth 5Y % 10.1 10.0
D/E 0.7 0.2

السعر المستهدف للمحللين

Hold
KWD 428.670 +30.5%
Low: KWD 390.000 High: KWD 469.000
مكرر الربحية المستقبلي
22.2
ربحية السهم المستقبلية
KWD 15.013
نمو ربحية السهم (تقدير)
+0.0%
الإيرادات المقدّرة
27 B

تقديرات الأرباح

الفترة تقدير ربحية السهم تقدير الإيرادات المحللون
FY2030 KWD 22.823
KWD 22.266 – KWD 23.203
 38 B 2
FY2029 KWD 21.030
KWD 20.516 – KWD 21.380
 35 B 4
FY2028 KWD 18.716
KWD 16.948 – KWD 20.124
 32 B 6

Insider Trading Activity

18 transactions
Date Insider Type Shares Price Value
Mar 9, 2026
Lobo Kevin
Chair and CEO
 grant 50,332 — —
Mar 9, 2026
Menon Viju
Group President
 grant 9,320 — —
Mar 9, 2026
Stiles Spencer S
President and COO
 grant 14,912 — —
Feb 23, 2026
STRYKER RONDA E
Director
 other 55,600 — —
Feb 4, 2026
Fink M Kathryn
VP, Chief HR Officer
 grant 5,654 — —
Feb 4, 2026
King Debra
See Remarks
 grant 3,992 — —
Feb 4, 2026
Wells Preston Wendell
VP, Chief Financial Officer
 grant 11,974 — —
Feb 3, 2026
Stiles Spencer S
President and COO
 other 35,372 KWD 96.640 —
Nov 21, 2025
Pierce James Andrew
Group President
 other 422 — —
Nov 14, 2025
Berry William E Jr
VP, Chief Accounting Officer
 other 12,822 KWD 154.140 —
Nov 14, 2025
Berry William E Jr
VP, Chief Accounting Officer
 sell 1,953 KWD 365.490 KWD 713,802
Aug 1, 2025
Montagnino Kimberly Ann
VP, Chief Comm. Officer
 other 155 KWD 392.730 KWD 60,873
May 12, 2025
Berry William E Jr
VP, Chief Accounting Officer
 sell 1,241 KWD 388.560 KWD 482,202
May 8, 2025
Caforio Giovanni
Director
 grant 560 — —
May 8, 2025
McCoy Sherilyn S
Director
 grant 560 — —
May 8, 2025
Suri Rajeev
Director
 grant 560 — —
May 8, 2025
Silvernail Andrew K
Director
 grant 560 — —
May 8, 2025
BRAINERD MARY K
Director
 grant 560 — —

النقاط الرئيسية

Revenue grew 10.07% annually over 5 years — strong growth
ROE of 15.08% — decent returns on equity
Generating 4.28B in free cash flow
P/E of 38.73 — premium valuation
Cash machine — converts 131.95% of earnings into free cash flow
Capital efficient — spends only 3.03% of revenue on capex

النمو

Revenue Growth (5Y)
10.07%
Revenue (1Y)11.16%
Earnings (1Y)8.45%
FCF Growth (3Y)16.87%

الجودة

Return on Equity
15.08%
ROIC9.84%
Net Margin12.92%
Op. Margin19.47%

الأمان

Debt / Equity
0.66
Current Ratio1.89
Interest Coverage8.05

التقييم

P/E Ratio
38.73
P/B Ratio5.61
EV/EBITDA27.93
Dividend Yield0.01%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 11.16% Revenue Growth (3Y) 10.69%
Earnings Growth (1Y) 8.45% Earnings Growth (3Y) 1.27%
Revenue Growth (5Y) 10.07% Earnings Growth (5Y) 12.96%
Profitability
Revenue (TTM) 25.12B Net Income (TTM) 3.25B
ROE 15.08% ROA 6.78%
Gross Margin 63.96% Operating Margin 19.47%
Net Margin 12.92% Free Cash Flow (TTM) 4.28B
ROIC 9.84% FCF Growth (3Y) 16.87%
Safety
Debt / Equity 0.66 Current Ratio 1.89
Interest Coverage 8.05 Dividend Yield 0.01%
Valuation
P/E Ratio 38.73 P/B Ratio 5.61
P/S Ratio 5.01 PEG Ratio 5.16
EV/EBITDA 27.93 Dividend Yield 0.01%
Market Cap 125.72B Enterprise Value 136.57B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 25.12B 22.60B 20.50B 18.45B 17.11B
Net Income 3.25B 2.99B 3.17B 2.36B 1.99B
EPS (Diluted) 8.40 7.76 8.25 6.17 5.22
Gross Profit 16.07B 13.98B 12.49B 11.04B 10.71B
Operating Income 4.89B 5.06B 4.28B 3.73B 3.76B

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 47.84B 42.97B 39.91B 36.88B 34.63B
Total Liabilities 25.42B 22.34B 21.32B 20.27B 19.75B
Shareholders' Equity 22.42B 20.63B 18.59B 16.62B 14.88B
Total Debt 14.86B 14.12B 13.49B 13.53B 12.90B
Cash & Equivalents 4.01B 3.65B 2.97B 1.84B 2.94B
Current Assets 14.76B 14.85B 12.52B 10.28B 10.02B
Current Liabilities 7.79B 7.62B 7.92B 6.30B 4.55B

درجات الاستراتيجيات

This stock passed the criteria for 1 strategy

Score = fit strength (0–100)
Rank = position among all matches
Custom Cash Flow Compounder
#436 of 1052
48

النشاط الأخير

دخل Cash Flow Compounder
Mar 24, 2026